2026 NPPES data Cardiovascular Disease Physician NPI 1013083179 MD
Verify on CMS →

MEHRDAD JAFARZADEH, MD

Cardiovascular Disease Physician in CARMICHAEL, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 577 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.5085/100
▲ 13 pts above national avg 83.1 · [object Object]

What the federal data shows

MEHRDAD JAFARZADEH, MD reported a CMS MIPS final score of 96.5085/100 — above the 83.1 national average — and filed 5,121 Medicare Part D claims in 2023.

96.5085/100
MIPS score · +13 vs avg
5K
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MEHRDAD JAFARZADEH, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

97 Top 17% higher than 83% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MEHRDAD JAFARZADEH, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MEHRDAD JAFARZADEH, MD?

High performer (top quartile)

NPI registry status

Active

Issued 11/28/2006

NPI 1013083179

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

5,121 69% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

MIPS final score

96.5085/100 13.408500000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Cardiovascular Disease Physician compares to other specialties among California providers

California providers

Cardiovascular Disease Physician share within California

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within California

Medicare quality performance — MIPS

MEHRDAD JAFARZADEH, MD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average

High performer (top quartile)
MIPS Final Score
96.5085/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cardiovascular Disease Physician) — 96.5085/100 vs national avg 83.1

0%100%National avg83%96.5%
MIPS final score (Cardiovascular Disease Physician) — 96.5085/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MEHRDAD JAFARZADEH, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at 6401 COYLE AVE STE 416, CARMICHAEL, CA, 95608, with a listed phone of (916) 966-3501. NPI 1013083179 was issued on 11/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JAFARZADEH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,121 prescription claims written by this provider, covering 577 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.5085/100 for the 2023 performance year (Quality 80.342), compared with the national average of 83.1.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6401 COYLE AVE STE 416
CARMICHAEL, CA 95608

Provider Details

NPI 1013083179
Specialty Cardiovascular Disease Physician
Credentials MD
Gender Male
NPI Issued 11/28/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.5085
Final Score
Avg: 83.1
80.342
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MEHRDAD JAFARZADEH, MD. To verify MEHRDAD JAFARZADEH, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MEHRDAD JAFARZADEH, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 5,121 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,121
Total Claims
$1.0M
Total Drug Cost
577
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
12,478
Total Day Supply
372,717
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$909K
Generic Drug Cost
$124K

Patient Demographics

Average Patient Age
77.6 years
Avg HCC Risk Score
1.80
Gender Split
50% female / 50% male
Age Distribution
<65: 20, 65-74: 203, 75-84: 219, 85+: 135

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MEHRDAD JAFARZADEH, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Metoprolol Succinate
570
Eliquis
Apixaban
539
Atorvastatin Calcium
438
Carvedilol
298
Amlodipine Besylate
291
Metoprolol Tartrate
274
Losartan Potassium
260
Lisinopril
248
Clopidogrel
Clopidogrel Bisulfate
168
Furosemide
154

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How MEHRDAD JAFARZADEH, MD fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

MEHRDAD JAFARZADEH, MD's 5,121 claims are above the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as JAFARZADEH.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MEHRDAD JAFARZADEH, MD's specialty?
MEHRDAD JAFARZADEH, MD specializes in Cardiovascular Disease Physician and practices in CARMICHAEL, California. Credentials: MD.
How much does MEHRDAD JAFARZADEH, MD prescribe under Medicare Part D?
In 2023, MEHRDAD JAFARZADEH, MD wrote 5,121 Medicare Part D claims totaling $1.0M in drug costs for 577 beneficiaries.
What is MEHRDAD JAFARZADEH, MD's Medicare quality score?
MEHRDAD JAFARZADEH, MD has a CMS MIPS Final Score of 96.5085/100 (Quality: 80.342). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MEHRDAD JAFARZADEH, MD located?
MEHRDAD JAFARZADEH, MD is located at 6401 COYLE AVE STE 416, CARMICHAEL, CA, 95608. Phone: (916) 966-3501.
What is MEHRDAD JAFARZADEH, MD's NPI number?
MEHRDAD JAFARZADEH, MD's National Provider Identifier (NPI) is 1013083179, issued on 11/28/2006.
Does MEHRDAD JAFARZADEH, MD prescribe more brand-name or generic drugs?
MEHRDAD JAFARZADEH, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $909K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does MEHRDAD JAFARZADEH, MD prescribe most often?
Based on 2023 Medicare Part D data, MEHRDAD JAFARZADEH, MD's most frequently prescribed drugs include Metoprolol Succinate, Eliquis, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MEHRDAD JAFARZADEH, MD accept Medicare?
MEHRDAD JAFARZADEH, MD appears in CMS Medicare data with 5,121 Part D claims and 577 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MEHRDAD JAFARZADEH, MD's credentials?
MEHRDAD JAFARZADEH, MD's NPI is 1013083179 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology